Potential Anticonvulsants. 11. Synthesis and Anticonvulsant Activity of Spiro[1,3-dioxolane-2,3′-indolinl]2′-ones and Structural Analogues

Journal of Medicinal Chemistry

Volumn 31, Issue 5, 1988, Pages 1001-1005

  Rajopadhyet, Milind ^a   Popp, Frank D ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONVULSION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN;

ANIMAL; ANTICONVULSANTS; CHEMISTRY; DRUG EVALUATION, PRECLINICAL; EQUILIBRIUM; INDOLES; MALE; MICE; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T;

EID: 0023895799     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00400a018     Document Type: Article

References (30)

1. Swinyard, E. A. In Antiepileptic Drugs; Woodbury, D. M., Penry, J. K., Pippenger, C. E., Eds.; Raven: New York, 1982; p 1.
2. Mercier, J. In Anticonvulsant Drugs; Mercier, J., Ed.; Pergamon: Oxford, 1973; p 203.
3. Anticonvulsants; Vida, J. A., Ed.; Academic: New York, 1977.
4. Popp, F. D. In Anticonvulsants; Vida, J. A., Ed.; Academic: New York, 1977; pp 331.
5. Popp, F. D. Adv. Heterocycl. Chem. 1975, 18, 1.
6. Popp, F. D. J. Heterocycl. Chem. 1984, 21, 1641.
7. Rajopadhye, M.; Popp, F. D. J. Heterocycl. Chem. 1984, 21, 289.
8. Pajouhesh, H.; Parson, R.; Popp, F. D. J. Pharm. Sci. 1983, 72, 318.
9. Popp, F. D. J. Heterocycl. Chem. 1982, 19, 589.
10. Popp, F. D.; Pajouhesh, H. J. Pharm. Sci. 1982, 71, 1052.
11. Popp, F. D.; Parson, R.; Donigan, B. E. J. Pharm. Sci. 1980, 69,1235.
12. Popp, F. D.; Donigan, B. E. J. Pharm. Sci. 1979, 68, 519.
13. Maryanoff, B. E.; Nortey, S. O.; Gardocki, J. F.; Shank, R. P.; Dodgson, S. P. J. Med. Chem. 1987,30, 880.
14. Maryanoff, B. E.; Nortey, S. O. U.S. Pat. 4591601, 1986
15. Maryanoff, B. E.; Nortey, S. O. Chem. Abstr. 1986, 105, 78920f.
16. Hardie, W. R.; Hidalgo, J.; Halverstadt, I. F.; Allen, R. E. J. Med. Chem. 1966, 9, 127.
17. Wenkert, E.; Bringi, N. V. J. Am. Chem. Soc. 1958, 80, 5575.
18. Wenkert, E.; Hudlicky, T. Synth. Commun. 1977, 7, 541.
19. Camerman, A.; Camerman, N. In Antiepileptic Drugs: Mechanism of Action; Glaser, G. H., Penry, J. K., Woodbury, D. M., Eds.; Raven: New York, 1980; p 223.
20. Vida, J. A.; Gerry, E. H. In Anticonvulsants; Vida, J. A., Ed.; Academic: New York, 1977. pp 191.
21. Wolf, M. U.S. Pat. 3 458 525, 1969.
22. Wolf, M. Chem. Abstr. 1970, 72, 21715p.
23. Joshi, K. C.; Jain, R.; Chand, P. Heterocycles 1985, 23, 957.
24. Borenstein, M. R.; Doukas, P. H. J. Pharm. Sci. 1987, 76, 300.
25. Gladding, G. D.; Kupferberg, H. J.; Swinyard, E. A. In Antiepileptic Drugs; Frey, H. H., Janz, D., Eds.; Springer Verlag: Berlin, 1985; p 341.
26. Codding, P. W.; Lee, T. A.; Richardson, J. F. J. Med. Chem. 1984, 27, 649.
27. Zhungietu, G. I.; Gorges, V. I.; Rekhter, M. A.; Korpan, A. I. Ser. Biol. Khim. Nauk. 1980, 61.
28. Zhungietu, G. I.; Chmykhova, N. I.; Gorgos, V. I.; Rekhter, M. A.; Khariton, K. S. Khim. Geterotsikl. Soedin. 1977, 642.
29. Kohn, H. J. Med. Chem. 1987, 30, 567.
30. Clark, C. R.; Davenport, T. W. J. Med. Chem. 1987, 30, 1214.